|Bid||38.05 x 1200|
|Ask||37.96 x 900|
|Day's Range||36.74 - 38.63|
|52 Week Range||31.21 - 76.89|
|Beta (5Y Monthly)||0.84|
|PE Ratio (TTM)||60.13|
|Earnings Date||May 05, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||65.00|
Investor confidence is high in Inogen (INGN) stock, thanks to solid prospects.
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
Joining me from Inogen is CEO, Scott Wilkinson; and CFO and Co-Founder, Ali Bauerlein. Earlier today, Inogen released financial results for the first quarter of 2020. As a reminder, the information presented today will include forward-looking statements, including without limitation statements about our growth prospects and strategy for 2020 and expectations regarding international sales and tender activity, the impact of COVID-19 public health emergency or PHE on our business and demand for our products and expectations regarding related reimbursement and regulatory changes.
Inogen (INGN) delivered earnings and revenue surprises of 36.36% and 6.69%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month period ended March 31, 2020.
With hospitals devoting nearly all their efforts to deal with the pandemic, elective procedures are being put on the backburner Continue reading...
Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release first quarter 2020 financial results after market close on Tuesday, May 5, 2020. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.
Inogen (NASDAQ:INGN) shares have had a really impressive month, gaining 31%, after some slippage. But shareholders may...
Inogen, Inc. (NASDAQ: INGN) announced today that due to the public health impact of the coronavirus (COVID-19) pandemic, and to support the health and well-being of its employees, stockholders, and other meeting participants, the company has changed the date, time and format of its 2020 Annual Meeting of Stockholders ("Annual Meeting"). The Annual Meeting will now be held at 9:00 a.m. Pacific time on Monday, May 11, 2020 by means of a virtual meeting format only instead of the date, time and location previously disclosed in Inogen’s proxy materials filed with the Securities and Exchange Commission on March 24, 2020.
Even the best stock pickers will make plenty of bad investments. And there's no doubt that Inogen, Inc. (NASDAQ:INGN...
It's been a good week for Inogen, Inc. (NASDAQ:INGN) shareholders, because the company has just released its latest...
Inogen (INGN) delivered earnings and revenue surprises of -36.36% and 0.02%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
If you're interested in Inogen, Inc. (NASDAQ:INGN), then you might want to consider its beta (a measure of share price...